According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence ...

Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. This agreement builds on a clinical collaboration between the companies pursuant to ...

An Osaka Metropolitan University research team analyzed how diabetes mellitus and obesity factor into recurrence and survival ...

A court ruled in favor of Exelixis in the oncology company's patent-infringement lawsuit against MSN Laboratories.

ALAT = alanine aminotransferase, ASAT = aspartate aminotransferase, GGT = gamma glutamyl transferase, PPT = partial thromboplastin time, IgA = immunoglobulin A, IgG = immunoglobulin G, AFP = alpha ...

Biotechnology company Tempest Therapeutics, Inc. (TPST) announced Thursday an agreement with Roche Group (RHHBY.PK) to advance the ...

Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information in this primary liver cancer section is mostly about ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...